Skip to main content
Clinical Trials/NCT05357521
NCT05357521CompletedNot Applicable

Feasibility and Preliminary Data on the Interplay Between Oxytocin and Cortisol During Stress in Borderline Personality Disorder

University of Geneva, Switzerland1 site in 1 country100 target enrollmentStarted: March 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Salivary cortisol

Study Overview

Brief Summary

This study aims to determine the feasibility and preliminary data on the interaction between oxytocin and cortisol during stress in borderline personnality disorder.

Detailed Description

The investigators will recruit 50 female patients with borderline personnality disorder and 50 controls with no psychiatric diagnosis, aged between 18 and 25 years old.

salivary cortisol daily curve ( 6 measures during the day) will be measured in participant's naturalistic environnement, together with salivary oxytocin. In addition, salivary oxytocin and cortisol will be measured during a psychosocial stress task and recovery.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Borderline personality disorder-DSM V

Exclusion Criteria

  • •Schizophrenia

Outcomes

Primary Outcomes

Salivary cortisol

Time Frame: Change during experimental task (up to 2 hours)

salivary cortisol measured with salivettes (swabs)

Salivary oxytocin

Time Frame: Change during experimental task (up to 2 hours)

salivary oxytocin measured with salivettes (swabs)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Geneva, Switzerland
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tatiana Aboulafia Brakha

PhD

University of Geneva, Switzerland

Study Sites (1)

Loading locations...

Similar Trials